FibroGen, Inc. (FGEN)

8.38 -0.32 (-3.68%) USD  |  NASDAQ  |  Dec 12, 16:00
8.435 +0.06 (+0.66%) After-Hours: 20:00
More

FibroGen Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for FGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Assertio Holdings, Inc. Upgrade
Harrow, Inc. Upgrade
Skye Bioscience, Inc. --
Theravance Biopharma, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade